TCT 2024

View a showcase of novel data on interventional techniques, treatments, and breakthroughs from TCT 2024, which took place October 27-30 in Washington, DC.

Novel Catheter Method Can Successfully Treat Heart Infections Without Surgery

Laura LitwinInterventional Cardiology | November 8, 2024

Mayo Clinic researchers identified a new approach to treating infective endocarditis using a catheter-based method.

EARLY TAVR for Asymptomatic Severe Aortic Stenosis Slices Adverse Outcomes in Half, But Caveats Remain

Amit Goyal, MDTCT 2024 | November 7, 2024

Results of the EARLY TAVR trial introduced a potential paradigm shift in managing asymptomatic high-gradient severe AS.

EARLY TAVR and EVOLVED Trials Offer Divergent Conclusions but Similar Results for AVR in Patients with Asymptomatic Severe Aortic Stenosis

Amit Goyal, MDTCT 2024 | December 4, 2024

Two pivotal trials—EARLY TAVR and EVOLVED—were presented, each exploring early intervention in asymptomatic severe AS.

ECLIPSE on Orbital Atherectomy: Balloon Angioplasty Still Shines in Calcified Lesions

Amit Goyal, MDTCT 2024 | December 4, 2024

ECLIPSE investigated whether OA provides better outcomes than conventional balloon angioplasty in calcified coronary lesions.

Regional Benefits? U.S. Cohort Shows Stroke Reduction in PROTECTED TAVR Analysis with Use of Cerebral Embolic Protection

Amit Goyal, MDTCT 2024 | December 4, 2024

An analysis of PROTECTED TAVR trial highlighted potential regional differences in the efficacy of CEP during TAVR.

Sirolimus-Coated Balloons Yield Similar Efficacy to Paclitaxel-Coated Balloons in Treating PAD

Rob DillardTCT 2024 | October 30, 2024

Sirolimus-coated balloons are non-inferior to paclitaxel-coated balloons in patients with femoropopliteal artery disease.